Atlas Trials

A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.

Clinical trial NCT02400775 · WITHDRAWN

Trial details

NCT number
NCT02400775
Sponsor
Takeda
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Essential Hypertension With Stable Angina and Dyslipidemia
Start date
2015-03-01
Primary completion
2016-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.